Piper Therapeutics is focused on higher order pathways that govern immune and inflammatory response. The company is developing therapies to promote a microenvironment to inhibit tumor growth, slow sepsis, and calm autoimmune disease.
Company (Alive / Active)
Massachusetts, United States
|Investor||Investor Type||Location||Participating Rounds|
|Title||Application Date||Patent Date||Status
(Patent / Application)